Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 7/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.39 |
| ▸ | MET | P08581 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 2/20 | 0.38 |
| ▸ | ESRRG | P62508 | 2/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12440639 | 0.89 | MCHR1 (0.48) | HTR7MCHR1METHTR6 | |
| SCHEMBL215782 | 0.79 | HTR7 (0.56) | HTR7NOS3NOS1NOS2ESRRG | |
| SCHEMBL12440204 | 0.79 | MCHR1 (0.39) | HTR7MCHR1METHTR6HRH3 | |
| SCHEMBL4263907 | 0.78 | HTR7 (0.54) | HTR7NOS3NOS1NOS2HTR6 | |
| SCHEMBL2262498 | 0.78 | HTR7 (0.54) | HTR7NOS3NOS1NOS2HTR6 | |
| SCHEMBL12440514 | 0.77 | HTR7 (0.39) | HTR7MCHR1METHTR6 | |
| SCHEMBL20784089 | 0.76 | HTR7 (0.59) | HTR7NOS3NOS1NOS2 | |
| SCHEMBL20604809 | 0.75 | HTR7 (0.49) | HTR7NOS3NOS1NOS2MET | |
| SCHEMBL12441448 | 0.74 | HRH3 (0.44) | HTR7MCHR1METHRH3 | |
| SCHEMBL14767429 | 0.73 | MCHR1 (0.46) | NOS3NOS1NOS2MCHR1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1558578-B1 | NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM PHARMA (DE) | 2013-03-13 | — | — | EP | disclosed |